Sarco/endoplasmic Reticulum Ca2+-ATPase (SERCA) Activity is Required for V(D)J Recombination
Overview
General Medicine
Authors
Affiliations
A whole-genome CRISPR/Cas9 screen identified ATP2A2, the gene encoding the Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 2 protein, as being important for V(D)J recombination. SERCAs are ER transmembrane proteins that pump Ca2+ from the cytosol into the ER lumen to maintain the ER Ca2+ reservoir and regulate cytosolic Ca2+-dependent processes. In preB cells, loss of SERCA2 leads to reduced V(D)J recombination kinetics due to diminished RAG-mediated DNA cleavage. SERCA2 deficiency in B cells leads to increased expression of SERCA3, and combined loss of SERCA2 and SERCA3 results in decreased ER Ca2+ levels, increased cytosolic Ca2+ levels, reduction in RAG1 and RAG2 gene expression, and a profound block in V(D)J recombination. Mice with B cells deficient in SERCA2 and humans with Darier disease, caused by heterozygous ATP2A2 mutations, have reduced numbers of mature B cells. We conclude that SERCA proteins modulate intracellular Ca2+ levels to regulate RAG1 and RAG2 gene expression and V(D)J recombination and that defects in SERCA functions cause lymphopenia.
CBP/CREB Regulates the Proliferation and Apoptosis of Cardiomyocytes by Interacting With SERCA.
Zhouguo Y, Yuan Z, Abdul M, Xi S, Wei T, Yan W J Cell Mol Med. 2025; 29(4):e70426.
PMID: 39969158 PMC: 11837278. DOI: 10.1111/jcmm.70426.
Wang M, Zhang Q, Ju R, Xia J, Xu C, Chen W Animals (Basel). 2025; 15(3).
PMID: 39943104 PMC: 11816060. DOI: 10.3390/ani15030334.
Ca homeostasis: a potential target for cancer therapies.
Su M, Zheng S, Liu H, Tang T, Hu Y Biophys Rep. 2024; 10(5):283-292.
PMID: 39539289 PMC: 11554574. DOI: 10.52601/bpr.2024.230023.
Targeting SERCA2 in Anti-Tumor Drug Discovery.
Song W, Zhang Q, Cao Z, Jing G, Zhan T, Yuan Y Curr Drug Targets. 2024; 26(1):1-16.
PMID: 39323343 DOI: 10.2174/0113894501325497240918042654.
Comprehensive summary: the role of PBX1 in development and cancers.
Liu M, Xing Y, Tan J, Chen X, Xue Y, Qu L Front Cell Dev Biol. 2024; 12:1442052.
PMID: 39129784 PMC: 11310070. DOI: 10.3389/fcell.2024.1442052.